Clovis Oncology Has Returned 78.3% Since SmarTrend Recommendation (CLVS)

SmarTrend identified an Uptrend for Clovis Oncology (NASDAQ:CLVS) on May 18th, 2017 at $52.70. In approximately 2 months, Clovis Oncology has returned 78.27% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.